These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2378)

  • 1. Studies on fazadinium bromide (ah 8165): a new non-depolarizing neuromuscular blocking agent.
    Hughes R; Payne JP; Sugai N
    Can Anaesth Soc J; 1976 Jan; 23(1):36-47. PubMed ID: 2378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and neuromuscular effects of dimethyl tubocurarine in anaesthetized cats and rhesus monkeys.
    Hughes R; Chapple DJ
    Br J Anaesth; 1976 Sep; 48(9):847-52. PubMed ID: 183800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects on non-depolarizing neuromuscular blocking agents on peripheral autonomic mechanisms in cats.
    Hughes R; Chapple DJ
    Br J Anaesth; 1976 Feb; 48(2):59-68. PubMed ID: 130154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on dimethyl tubocurarine in anaesthetized man.
    Hughes R; Ingram GS; Payne JP
    Br J Anaesth; 1976 Oct; 48(10):969-74. PubMed ID: 791310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of single twitch and train-of-four responses and of tetanic fade in relation to plasma concentrations of fazadinium in man.
    d'Hollander AA; Duvaldestin P; Delcroix C; Nevelsteen M; Desmonts JM
    Anesth Analg; 1982 Mar; 61(3):225-30. PubMed ID: 6121521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental and clinical evaluation of neuromuscular blocking agents.
    Hughes R
    J Pharmacol Methods; 1984 Aug; 12(1):1-27. PubMed ID: 6100317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative potency and speed of onset of fazadinium and d-tubocurarine.
    Hussain SZ; Healy TE; Birmingham AT
    Acta Anaesthesiol Scand; 1979 Aug; 23(4):331-5. PubMed ID: 40380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of halothane with non-depolarizing neuromuscular blocking drugs in man.
    Hughes R; Payne JP
    Br J Clin Pharmacol; 1979 May; 7(5):485-90. PubMed ID: 157769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors limiting the rate of termination of the neuromuscular blocking action of fazadinium dibromide.
    Tyers MB
    Br J Pharmacol; 1978 Jun; 63(2):287-93. PubMed ID: 27272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular blocking and cardiovascular effects of Org 9487, a new short-acting aminosteroidal blocking agent, in anaesthetized animals and in isolated muscle preparations.
    Muir AW; Sleigh T; Marshall RJ; Pow E; Anderson KA; Booij LH; Hill DR
    Eur J Anaesthesiol; 1998 Jul; 15(4):467-79. PubMed ID: 9699106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular blockade of fazadinium bromide (AH 8165) in renal failure patients.
    Camu F; D'Hollander A
    Acta Anaesthesiol Scand; 1978; 22(3):221-6. PubMed ID: 27936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of speed of onset of fazadinium, pancuronium, tubocurarine and suxamethonium.
    Blackburn CL; Morgan M
    Br J Anaesth; 1978 Apr; 50(4):361-4. PubMed ID: 26369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential changes in the fade of tetanic tension after the administration of tubocurarine in anaesthetized man.
    Sugai N; Hughes R; Payne JP
    Br J Anaesth; 1976 Jun; 48(6):535-9. PubMed ID: 952688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The skeletal muscle response to edrophonium during neuromuscular blockade by tubocurarine in anaesthetized man.
    Sugai N; Payne JP
    Br J Anaesth; 1975 Oct; 47(10):1087-92. PubMed ID: 1106740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of fazadinium in children. An electromyographic study.
    Esener Z
    Br J Anaesth; 1983 Dec; 55(12):1205-12. PubMed ID: 6140023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical model of some pharmacokinetic and pharmacodynamic properties of fazadinium in man.
    d'Hollander AA; Delcroix C; Duvaldestin P; Henzel D; Coussaert E; Desmonts JM
    Eur J Clin Pharmacol; 1983; 24(3):407-13. PubMed ID: 6134623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical assessment of atracurium using the single twitch and tetanic responses of the adductor pollicis muscles.
    Hughes R; Payne JP
    Br J Anaesth; 1983; 55 Suppl 1():47S-52S. PubMed ID: 6688017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromuscular pharmacology of TAAC3, a new nondepolarizing muscle relaxant with rapid onset and ultrashort duration of action.
    Gyermek L; Lee C; Cho YM; Nguyen N; Tsai SK
    Anesth Analg; 2002 Apr; 94(4):879-85, table of contents. PubMed ID: 11916790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetanic fade during partial transmission failure produced by non-depolarizing neuromuscular blocking drugs in the cat.
    Bowman WC; Webb SN
    Clin Exp Pharmacol Physiol; 1976; 3(6):545-55. PubMed ID: 188580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
    Naguib M; Abdulatif M; al-Ghamdi A
    Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.